山东大学学报 (医学版) ›› 2018, Vol. 56 ›› Issue (10): 51-57.doi: 10.6040/j.issn.1671-7554.0.2018.1027
杜鲁涛1,2,赵巧辉3,田晓平3,吴学炜4,付光宇4,渠海4, 苗拥军4,王丽丽5,郑桂喜5,郭海洋6,李桂林3,王传新1,2
DU Lutao1,2, ZHAO Qiaohui3, TIAN Xiaoping3, WU Xuewei4, FU Guangyu4, QU Hai4, MIAO Yongjun4, WANG Lili5, ZHENG Guixi5, GUO Haiyang6, LI Guilin3, WANG Chuanxin1,2
摘要: 目的 获得针对CA50靶点的高亲和力、高特异性抗体,建立体外诊断CA50检测试剂盒,提高肿瘤诊断的特异性和灵敏度。 方法 PCR 技术获得单链抗体( ScFv)基因并克隆入pcomb3XSS噬粒载体,通过电转化获得ScFv噬菌体抗体库。用CA50特性识别表位LST a(唾液酸化-乳糖-N-四糖a)的抗原淘洗筛选,获得针对CA50靶点的特异性抗体基因序列。随机挑选克隆测序,验证ScFv抗体库的多样性。利用重叠PCR技术获得人鼠嵌合抗体基因,经过抗体表达纯化及配对筛选建立双抗体夹心法CA50检测试剂盒。同时收集临床诊断阳性样本54例和临床阴性对照样本146例,利用该研究建立的CA50检测试剂盒与罗氏CA50试剂盒进行平行对照,评价其检测相关性。 结果 建立噬菌体抗体库的容量为2.5×108,具有较好的多样性。24个PCR鉴定阳性克隆测序,结果为20个正确插入且插入序列均不相同。经过3轮淘洗筛选出5个阳性克隆,经过抗体配对筛选建立的CA50试剂盒临床样本检测结果与罗氏的临床相关性(r=0.98)。 结论 通过噬菌体展示抗体库技术成功筛选出了针对CA50的高特异性、高亲和力抗体,为CA50检测在相关肿瘤辅助诊断中的应用提供可能性。
中图分类号:
| [1] Lourdes, Roque-Navarro, Krittalak, et al. Anti-ganglioside antibody-induced tumor cell death byloss of membrane integrity [J]. Mol Cancer Ther, 2008, 7(7): 2033-2041. [2] Wu JH, Hao PP, Chen YG, et al. Intracoronary glycoprotein IIb/IIIa inhibitors improve short-Term mortality and reinfarction in east asian patients with sT-Segment elevation myocardial infarction after thrombus aspiration: a meta-analysis [J]. Evid Based Complement Alternat Med, 2018, 2018: 5174714. doi: 10.1155/2018/5174714. [3] Grainger JD, Thachil JandWill AM. How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults [J]. Br J Haematol, 2018, 182(5): 621-632. [4] Reilly SW, Puentes LN, Hsieh CJ, et al. Altering Nitrogen Heterocycles of AZD2461 Affords High Affinity Poly(ADP-ribose)Polymerase-1 Inhibitors with Decreased P-Glycoprotein Interactions [J]. ACS Omega, 2018, 3(8): 9997-10001. [5] Llop E, P EG, Duran A, et al. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma [J]. World J Gastroenterol, 2018, 24(24): 2537-2554. [6] Nishibori M, Wake HandMorimatsu H. Histidine-rich glycoprotein as an excellent biomarker for sepsis and beyond [J]. Critical care, 2018, 22(1): 209. [7] Shah AK, Hartel G, Brown I, et al. Evaluation of serum glycoprotein biomarker candidates for detection of esophageal adenocarcinoma and surveillance of Barrett's esophagus [J]. Mol Cell Proteomics, 2018. pii: mcp. RA118.000734.doi:10.1074/mcp.RA118.000734. [8] Wang X, Lin JM, Ying X. Evaluation of carbohydrate antigen 50 in human serum using magnetic particle-based chemiluminescence enzyme immunoassay [J]. Anal Chim Acta, 2007, 598(2): 261-267. [9] Woldike PM, Charib K,Siboni A. [Use of tumor marker CA50] [J]. Ugeskr Laeger, 2008, 170(38): 2985. [10] Liao Q, Zhao YP, Yang YC, et al. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head [J]. Hepatobiliary Pancreat Dis Int, 2007, 6(6): 641-645. [11] 段泽星, 罗俊卿, 李伟强, 等. 血清CEA、CA242、CA50、CA19-9对结直肠癌诊断和生物学特性评估的意义[J]. 胃肠病学, 2014, 19(4): 217-220. DUAN Zexing, LUO Junqing, LI Weiqiang, et al. Significance of serum CEA, CA242, CA50, and ca19-9 in diagnosis and evaluation of biological characteristics colorectal cancer [J]. Chinese Journal of Gastroenterology, 2014, 19(4): 217-220. [12] 陶晓军, 冯晓鸿, 孙业富. CA72-4、CA19-9、CA50、CA242联合检测在胃癌诊断中的应用[J]. 实验与检验医学, 2012, 30(2): 169-171. [13] 尹莉莉, 杜叶平, 武春梅. 血清CA50与CA199联合检测在胰腺癌诊断中的意义[J]. 解放军医药杂志, 2013, 25(1): 31-32. YIN Lili,DU Yeping,WU Chunmei. Significance of the Detection of Serum CA50 Combined with CA199 in Diagnosis of Pancreatic Cancer[J]. Medical & Pharmaceutical Journal of Chinese Peoples Liberation Army, 2013, 25(1): 31-32. [14] 朱剑峰, 李志辉, 朱红静, 等. CEA、CA199、CA724、CA242、CA125、CA50对消化道肿瘤的诊断价值[J]. 实用癌症杂志, 2014, 29(5): 501-502. ZHU Jianfeng, LI Zhihui, ZHU Hongjing, et al. Diagnostic value of CEA、CA199、CA724、CA242、CA125 and CA50 in gastrointestinal tumors[J]. The Practical Journal of Cancer, 2014, 29(5): 501-502. [15] Lindholm L, Holmgren J, Svennerholm L, et al. Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides[J]. In Archi Allergy Appl Immunol, 2009, 71(2):178-181. [16] Weiner GJ. Building better monoclonal antibody-based therapeutics [J]. Nat Rev Cancer, 2015, 15(6): 361-370. [17] Lei XF, Jia SZ, Ye J, et al. Application values of detection of serum CA199, CA242 and CA50 in the diagnosis of pancreatic cancer [J]. J Biol Regul Homeost Agents, 2017, 31(2): 383-388. [18] Watanabe M, Chigusa M, Takahashi H, et al. High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo [J]. In Vitro Cell Dev Biol Anim, 2000, 36(2): 104-109. [19] Xie M, Huang H, Hang J, et al. Evaluation of the analytical and clinical performances of time-resolved fluoroimmunoassay for detecting carcinoma antigen 50 [J]. J Immunoassay Immunochem, 2015, 36(3): 265-283. [20] Wei H, Hu J, Wang L, et al. Rapid gene splicing and multi-sited mutagenesis by one-step overlap extension polymerase chain reaction [J]. Anal Biochem, 2012, 429(1): 76-78. [21] Edenberg HJ, Moss LGandRutter WJ. Convenient vectors for cloning and sequencing EcoRI and HindIII fragments [J]. Gene, 1987, 58(2-3): 297-298. [22] Xu HX, Li S, Wu CT, et al. Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinoma [J]. Pancreatology, 2018, 18(6): 671-677. [23] Sauzay C, Petit A, Bourgeois AM, et al. Alpha-foetoprotein(AFP): A multi-purpose marker in hepatocellular carcinoma [J]. Clin Chim Acta, 2016, 463: 39-44. doi: 10.1016/j.cca.2016.10.006. [24] Liu L, Xu HX, Wang WQ, et al. Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden [J]. Oncotarget, 2016, 7(5): 5943-5956. [25] Peracaula R, Tabares G, Lopez-Ferrer A, et al. Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells [J]. Glycoconj J, 2005, 22(3): 135-144. [26] Romao E, Poignavent V, Vincke C, et al. Construction of high-quality camel immune antibody libraries [J]. Methods Mol Biol, 2018, 1701: 169-187. doi: 10.1007/978-1-4939-7447-4_9. [27] Tullila A and Nevanen TK. Utilization of multi-immunization and multiple selection strategies for isolation of hapten-specific antibodies from recombinant antibody phage display libraries [J]. Int J Mol Sci, 2017, 18(6). pii: E1169. doi: 10.3390/ijms18061169. |
| [1] | 李波波 李道堂 刘曙光 王兴武. 食管癌患者血清中DKK-1的表达[J]. 山东大学学报(医学版), 2209, 47(6): 58-61. |
| [2] | 徐平 于国放 李霞. 不同类型甲状腺上动脉PSV对Graves病与桥本氏甲状腺炎鉴别诊断的价值[J]. 山东大学学报(医学版), 2209, 47(6): 62-64. |
| [3] | 王欣,邢春燕,杨艳平. 血清磷酸丙酮酸水合酶检测对诊断侵袭性白念珠菌感染的临床价值[J]. 山东大学学报(医学版), 2209, 47(6): 92-94. |
| [4] | 山东省医学会心电学分会山东省医学伦理学学会心电学分会. 心电图报告规范化书写专家共识(2026)[J]. 山东大学学报 (医学版), 2026, 64(4): 1-7. |
| [5] | 中国医师协会骨科医师分会智能骨科学组,中华预防医学会脊柱疾病预防与控制专业委员会脊柱脊髓损伤疾病预防与控制学组. 人工智能脊柱退变影像学测量位点与标注专家共识(2025)[J]. 山东大学学报 (医学版), 2026, 64(2): 1-10. |
| [6] | 罗淇,王霞,姜孟. 脑功能网络分析在失语症诊疗中的应用:病理机制分析、临床诊断与疗效评价[J]. 山东大学学报 (医学版), 2025, 63(8): 111-126. |
| [7] | 河南省生物医学工程学会立体心电图专业委员会,中国医药教育协会心电学专业委员会,山东中医药学会心电学专业委员会,青岛市医学会心电生理与起搏专科分会,全国医药技术市场协会远程心脏专业委员会. 心电向量图诊断标准规范化专家共识(2025)[J]. 山东大学学报 (医学版), 2025, 63(7): 1-10. |
| [8] | 刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74. |
| [9] | 祝永才,谢艳,齐秋晨,李培龙,王传新,杜鲁涛. 基于外周血单个核细胞ATM基因甲基化的联合模型在胰腺癌早期诊断中的价值[J]. 山东大学学报 (医学版), 2025, 63(6): 78-88. |
| [10] | 蔡治清,董世菊,李乃坤,崔雪丹,王建伟,王亨. 基于熵权TOPSIS法的山东省某三级综合医院运营管理效能评价[J]. 山东大学学报 (医学版), 2025, 63(6): 107-116. |
| [11] | 温学龙,刘安慧,陈经纬,吴梦婷,杨岷. 急性非ST抬高型心肌梗死行冠状动脉旁路移植手术时机Meta分析[J]. 山东大学学报 (医学版), 2025, 63(5): 60-70. |
| [12] | 赵汉卿,周新睿,李子建,唐兴. 循环肿瘤细胞联合血清学检测在非小细胞肺癌中的应用[J]. 山东大学学报 (医学版), 2025, 63(5): 79-85. |
| [13] | 魏旭鹏,常成,赵秀鹤. 模拟多系统萎缩的抗Homer3抗体相关自身免疫性小脑共济失调1例并文献复习[J]. 山东大学学报 (医学版), 2025, 63(5): 95-100. |
| [14] | 赵芸慕兰,高海燕. 中、高危分化型甲状腺癌患者术后 131I治疗反应及预后的影响因素[J]. 山东大学学报 (医学版), 2025, 63(2): 21-28. |
| [15] | 崔倩倩,李金鹏,吴豫丹,侯志平,孙玮螺,崔盼盼,何培元. 粪便miRNA对结直肠进展期腺瘤无创筛查的临床价值[J]. 山东大学学报 (医学版), 2025, 63(2): 43-50. |
|
||